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A carbapenem- and pan-aminoglycoside-resistant Klebsiella pneumoniae strain was isolated from a Brazilian 
patient hospitalized in a Swiss hospital. The clinical isolate carried genes encoding the KPC-2 carbapenemase 
and the RmtG 16S rRNA methyltransferase. This is the ﬁrst report of a carbapenem-resistant K. pneumoniae 
producing RmtG in Europe.
Klebsiella pneumoniae is a leading cause of hospital-associated bacte-
rial infections. The acquisition of amultidrug resistance proﬁle has been
associated to the predominance of some speciﬁc sequence types (STs)
in clinical settings. Among the main threats, strains producing
carbapenemases are considered as the most worrying ones. In this re-
gard, carbapenem-resistant K. pneumoniae strains of clonal complex
258 (CC258 that includes ST11, ST258, ST340 and ST437) that produce
KPC-type carbapenemases have disseminated worldwide and have
been often responsible for nosocomial outbreaks (Woodford et al.,
2011). Worryingly, the co-occurrence of 16S rRNA methyltransferases,
such as ArmA, RmtB, RmtD, and RmtG enzymes, that confer high-level
and broad-spectrum resistance towards aminoglycosides has been in-
creasingly reported among KPC-producing K. pneumoniae in recent
years (Cerdeira et al., 2016; Cheng et al., 2016; Quiles et al., 2015).
Once KPC and a 16S rRNAmethyltransferase are co-produced, it almost
leads to pandrug resistance. We report here the emergence of a
K. pneumoniae of clonal complex 258 co-producing KPC-2 and RmtG
in Switzerland.
K. pneumoniae strain KP05–2017 was isolated from a rectal swab
upon admission in May 2017 in a Swiss hospital. It was recovered
from a 73-year-old patient who had been hospitalized in Brazil the
month before for treatment of a hemorrhagic shock caused by perfora-
tion of a gastric ulcer.
Disk diffusion assay (Sanoﬁ-diagnostic Pasteur, France) was per-
formed to test the antimicrobial susceptibility while E-test (bioMérieux,
La Balme-les-Grottes, France), and broth dilution techniques were used
to assess minimal inhibitory concentrations (MIC). Antimicrobial sus-
ceptibility was interpreted according to the CLSI guidelines. Isolate
KP05–2017 was resistant to ceftriaxone (MIC of 6 mg/L), but remained
susceptible to ceftazidime and cefepime (MIC of 3 and 8 mg/L, respec-
tively). It exhibited resistance to imipenem, ertapenemandmeropenem
with MICs b 32 mg/L. Carbapenemase activity was assessed using the
Carba NP test (Nordmann et al., 2012). Since the isolate was resistant
to amikacin, gentamicin, tobramycin and netilmicin, the occurrence of
a 16S rRNA methyltransferase was tested and conﬁrmed by using the
Rapid Aminoglycoside NP test that is based on a rapid culture of bacteria
in the presence of deﬁned concentrations of gentamicin and amikacin
(Nordmann et al., 2017). Isolate KP05–2017 was also resistant to
sulfonamide, nalidixic acid, ciproﬂoxacin, chloramphenicol, tetracy-
cline, trimethoprim-sulphamethoxazole and the combination of
ceftolozane-tazobactam (MIC 24 mg/L). It remained susceptible only
to fosfomycin and exhibited MIC values of colistin, the ceftazidime-
avibactam association and tigecycline at 2 mg/L, 1.5 mg/L, and
0.38 mg/L, respectively.
Multiplex PCRs performed to detect Ambler class A, B and D genes
and 16S rRNA methyltransferase genes (Bercot et al., 2011; Poirel
et al., 2011) followed by sequencing revealed the presence of the
blaKPC-2 and rmtG genes. Analysis of the plasmid content obtained
with the Kieser method (Kieser, 1984) identiﬁed three plasmids of ca.
10, 45 and 150 kb in size. Molecular proﬁling showed that KP05–2017
belongs to the sequence type 11. Mating-out assays were performed
to establish the transferability of the blaKPC-2 and rmtG genes using the
azide-resistant Escherichia coli J53 as recipient strain. Transconjugants
were selected on LB agar plates containing sodium azide (100 mg/L),
amikacin (50 mg/L) and gentamicin (50 mg/L), indicating the transfer-
ability of the ca. 45-kb plasmid carrying the rmtG gene. However, no
transconjugant was obtained when selecting on imipenem (1 mg/L).
Genomic DNA was subjected to whole genome sequencing using
an Illumina MiniSeq platform (Illumine, San Diego, CA, USA), which
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generated 4.564.240 reads with an average size of 144.3 bp. De novo as-
sembling of the reads was performed using CLC Genomics Workbench
version 7.5.1 (Qiagen, France). The ﬁnal size of the draft genome was
of 5.779.331 bp, with an average CG content of 56.8%.
The analysis of the resistome using ResFinder (https://cge.cbs.dtu.
dk/services/ResFinder/) identiﬁed genes conferring resistance to β-
lactams (blaTEM-1C and blaKPC-2), aminoglycosides (aadA2, aadA5, strA
and rmtG), macrolides, lincosamides and streptogramin B [erm(B) and
mph(A)], phenicols (cmlA1), sulphonamides (sul1 and sul2), trime-
thoprim (dfrA14, dfrA15 and drfA17) and tetracycline [tet(D)]. Plasmid
ﬁnder (https://cge.cbs.dtu.dk/services/PlasmidFinder/) revealed the
presence of the IncFIB(Mar) and IncB/O replicons, with the latter one
located in the 48 kB plasmid carrying the rmtG gene. PHASTER (http://
phaster.ca/) unveiled the presence of four intact, four incomplete and
three putative prophages.
The successful and worldwide dissemination of KPC-2 producing
K. pneumoniae strains belonging to CC258, which includes sequence
type 11, is now well established. The emergence of clones co-
producing 16S rRNA methyltransferases further complicates the treat-
ment of infections due to these pathogens, with extremely limited ther-
apeutic options left. The occurrence in Switzerland of a K. pneumoniae
clone co-producing KPC-2 and RmtG, with the latter enzyme being so
far reported in America and India (Bueno et al., 2013; Filgona et al.,
2015; Hu et al., 2014; Poirel et al., 2014), underlines how importation
of multidrug-resistant clones may occur despite the high standards of
antibiotic stewardship programs and hygiene control in effect in the
Swiss healthcare institutions.
Of note, and despite elevated MICs, isolate KP05–2017 remained
susceptible to ceftazidime and cefepime, suggesting a low-level of
expression of the blaKPC-2 gene. Notwithstanding, isolate KP05–2017
could grow on CHROMagar mSuperCarba chromID® (CHROMagar,
Paris, France), CARBA SMART and CHROMID® ESBLmedia (bioMérieux,
La Balme-les-Grottes, France) (data not shown), indicating that such
isolate, despite exhibiting low MICs of some broad-spectrum cephalo-
sporins, may be well detected with those screening media when used
for screening of carriers.
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